IMpassion130 study shows improved PFS in triple negative breast cancer
The phase III IMpassion130 study has met its co-primary endpoint of progression-free survival (PFS). This…
Browsing: IMpassion130
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- FDA grants accelerated approval to umbralisib for marginal zone lymphoma and follicular lymphoma
- Mathematical method developed to predict cancer and drug-specific immunotherapy efficacy
- Ultrasound technique treats prostate cancer with minimal side effects
- Landmark research toward increasing survival rates for aggressive childhood cancer
- Drug ‘breakthrough’ gives longest-ever survival in non-resectable liver cancer patients
- Samara Polytech scientists proved the anti-cancer properties of a number of plant extracts
- Combination therapy with radiation shows promise in treating glioblastoma
- New study discovers possible early detection method for elusive ovarian cancer
